.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
US Department of Justice
Novartis
Mallinckrodt
Accenture
Harvard Business School
QuintilesIMS
Chinese Patent Office
Dow
Cantor Fitzgerald

Generated: February 17, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0612540.5

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Noden PharmaTEKTURNA HCTaliskiren hemifumarate; hydrochlorothiazideTABLET;ORAL022107-001Jan 18, 2008RXYesNo➤ Sign Up➤ Sign UpY
Noden PharmaTEKTURNA HCTaliskiren hemifumarate; hydrochlorothiazideTABLET;ORAL022107-002Jan 18, 2008RXYesNo➤ Sign Up➤ Sign UpY
Noden PharmaTEKTURNA HCTaliskiren hemifumarate; hydrochlorothiazideTABLET;ORAL022107-003Jan 18, 2008RXYesYes➤ Sign Up➤ Sign UpY
Noden PharmaTEKTURNA HCTaliskiren hemifumarate; hydrochlorothiazideTABLET;ORAL022107-004Jan 18, 2008RXYesYes➤ Sign Up➤ Sign UpY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist